dr. balar on impact of durvalumab plus tremelimumab in bladder cancer
Published 6 years ago • 203 plays • Length 1:07Download video MP4
Download video MP3
Similar videos
-
1:33
dr. balar on results of durvalumab plus tremelimumab in bladder cancer
-
0:48
dr. balar on the future of immunotherapy in bladder cancer
-
0:52
dr. balar discusses the impact of immunotherapy on bladder cancer
-
0:06
copy of dr. balar discusses the impact of immunotherapy on bladder cancer
-
0:52
dr. black discusses the impact of durvalumab in bladder cancer
-
0:54
dr. balar on biomarkers of immunotherapy response in bladder cancer
-
1:52
dr. balar on immunotherapy treatment in bladder cancer
-
2:03
durvalumab fda approval for bladder cancer
-
1:57
dr. balar on remaining questions with immunotherapy in bladder cancer
-
1:09
dr. balar on improved outlook in metastatic bladder cancer
-
2:55
highlights of durvalumab for advanced bladder cancer
-
1:09
dr. balar on current and future standards of care in kidney cancer treatment
-
1:10
dr. powles discusses the future of durvalumab in bladder cancer
-
0:51
dr. balar on the approval of pembrolizumab for bladder cancer
-
1:43
dr. sonpavde discusses a study of fixed-dose durvalumab and tremelimumab in urothelial carcinoma
-
0:47
dr. balar on combinations with pembrolizumab for urothelial cancer
-
1:32
dr. balar discusses study of immunotherapy combination in bladder cancer
-
3:19
fda approval of durvalumab for advanced bladder cancer
-
1:00
dr. black on combinations with durvalumab in bladder cancer